Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Catalytic methyltransferase enzymes are a broad class of enzymes that catalyze the transfer of a methyl group from a donor molecule—almost always S-adenosylmethionine (SAM)—to diverse biological substrates including DNA, RNA, proteins, lipids, and small molecules[1][3][6][7]. They are essential regulators of epigenetic processes by methylating nucleic acids (DNA or RNA), thereby influencing gene expression, chromatin structure, and cellular differentiation without altering the underlying DNA sequence[1][3][7]. They also play critical roles in the post-translational modification of proteins, affecting protein-protein interactions, stability, and function[7]. Dysregulation of methyltransferase activity is associated with disease states such as cancer, developmental disorders, and some infections[1][7]. Therapeutically, specific methyltransferases (like DNA methyltransferases and RNA methyltransferases such as METTL3) are validated drug targets, with inhibitors in clinical or preclinical development against various cancers and other diseases[8][5][3]. However, the phrase "catalytic methyltransferase enzymes" is not the canonical name for a single target but rather refers generically to the enzymatic class with diverse family members and substrate preferences, so target-specific information (e.g., for DNMT1, DNMT3A, METTL3, etc.) should be provided for structured queries. Notes regarding correctness: - The term "catalytic methyltransferase enzymes" is overly broad and refers to an entire class of enzymes, not a specific molecule or therapeutic target[7]; therefore, is_incorrect is true for target specificity. - For structured data or drug discovery, specific methyltransferase enzyme names (e.g., DNA methyltransferase 1, METTL3) should be used rather than this umbrella term.
Inhibition of methyl group transfer to nucleic acids or proteins, Epigenetic modulation, Blockade of gene silencing or activation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Catalytic methyltransferase enzyme.